annual FCF:
$3.97B-$1.00B(-20.18%)Summary
- As of today (August 20, 2025), GSK annual free cash flow is $3.97 billion, with the most recent change of -$1.00 billion (-20.18%) on December 31, 2024.
- During the last 3 years, GSK annual FCF has fallen by -$2.28 billion (-36.50%).
- GSK annual FCF is now -54.44% below its all-time high of $8.72 billion, reached on December 31, 2008.
Performance
GSK Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$1.63B+$775.54M(+90.43%)Summary
- As of today (August 20, 2025), GSK quarterly free cash flow is $1.63 billion, with the most recent change of +$775.54 million (+90.43%) on June 30, 2025.
- Over the past year, GSK quarterly FCF has increased by +$1.08 billion (+194.53%).
- GSK quarterly FCF is now -61.77% below its all-time high of $4.27 billion, reached on December 31, 2018.
Performance
GSK quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$5.47B+$1.08B(+24.56%)Summary
- As of today (August 20, 2025), GSK TTM free cash flow is $5.47 billion, with the most recent change of +$1.08 billion (+24.56%) on June 30, 2025.
- Over the past year, GSK TTM FCF has dropped by -$374.98 million (-6.41%).
- GSK TTM FCF is now -45.56% below its all-time high of $10.05 billion, reached on June 30, 2010.
Performance
GSK TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
GSK Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.2% | +194.5% | -6.4% |
| 3 y3 years | -36.5% | +61.0% | -41.7% |
| 5 y5 years | -38.4% | -34.4% | -36.9% |
GSK Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -36.5% | at low | -39.0% | +409.7% | -41.7% | +185.8% |
| 5 y | 5-year | -42.7% | at low | -59.0% | +409.7% | -41.7% | +185.8% |
| alltime | all time | -54.4% | >+9999.0% | -61.8% | +137.1% | -45.6% | +850.2% |
GSK Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.63B(+90.4%) | $5.47B(+24.6%) |
| Mar 2025 | - | $857.59M(-35.5%) | $4.39B(+9.5%) |
| Dec 2024 | $3.97B(-20.2%) | $1.33B(-19.5%) | $4.01B(-25.1%) |
| Sep 2024 | - | $1.65B(+197.8%) | $5.36B(-8.3%) |
| Jun 2024 | - | $554.48M(+16.3%) | $5.85B(-1.9%) |
| Mar 2024 | - | $476.75M(-82.2%) | $5.96B(+20.3%) |
| Dec 2023 | $4.98B(-7.5%) | $2.68B(+25.1%) | $4.95B(+56.5%) |
| Sep 2023 | - | $2.14B(+221.2%) | $3.16B(+65.3%) |
| Jun 2023 | - | $665.87M(-226.3%) | $1.91B(-15.4%) |
| Mar 2023 | - | -$527.33M(-159.5%) | $2.26B(-57.6%) |
| Dec 2022 | $5.38B(-14.0%) | $886.96M(-0.2%) | $5.34B(-36.7%) |
| Sep 2022 | - | $889.07M(-12.4%) | $8.44B(-10.1%) |
| Jun 2022 | - | $1.01B(-60.1%) | $9.39B(+4.9%) |
| Mar 2022 | - | $2.55B(-36.2%) | $8.94B(+43.2%) |
| Dec 2021 | $6.26B(-9.8%) | $3.99B(+116.7%) | $6.25B(+8.3%) |
| Sep 2021 | - | $1.84B(+220.7%) | $5.77B(+39.0%) |
| Jun 2021 | - | $573.60M(-478.2%) | $4.15B(-31.6%) |
| Mar 2021 | - | -$151.68M(-104.3%) | $6.07B(-12.5%) |
| Dec 2020 | $6.93B(+7.6%) | $3.51B(+1490.2%) | $6.93B(+9.1%) |
| Sep 2020 | - | $220.67M(-91.1%) | $6.35B(-26.8%) |
| Jun 2020 | - | $2.49B(+249.7%) | $8.67B(+28.5%) |
| Mar 2020 | - | $711.67M(-75.7%) | $6.75B(+5.7%) |
| Dec 2019 | $6.44B(-19.1%) | $2.93B(+15.2%) | $6.38B(-17.4%) |
| Sep 2019 | - | $2.54B(+347.8%) | $7.73B(+6.5%) |
| Jun 2019 | - | $567.66M(+64.5%) | $7.26B(-5.9%) |
| Mar 2019 | - | $345.12M(-91.9%) | $7.71B(-3.8%) |
| Dec 2018 | $7.96B(+54.3%) | $4.27B(+106.1%) | $8.01B(+30.8%) |
| Sep 2018 | - | $2.07B(+103.3%) | $6.13B(+5.0%) |
| Jun 2018 | - | $1.02B(+56.9%) | $5.83B(+17.2%) |
| Mar 2018 | - | $649.87M(-72.7%) | $4.98B(-3.2%) |
| Dec 2017 | $5.16B(+8.8%) | $2.38B(+33.7%) | $5.14B(-2.6%) |
| Sep 2017 | - | $1.78B(+1003.2%) | $5.28B(+1.3%) |
| Jun 2017 | - | $161.50M(-80.2%) | $5.21B(-10.5%) |
| Mar 2017 | - | $816.59M(-67.6%) | $5.82B(+22.7%) |
| Dec 2016 | $4.74B(>+9900.0%) | $2.52B(+47.0%) | $4.74B(+56.4%) |
| Sep 2016 | - | $1.71B(+122.1%) | $3.03B(+136.5%) |
| Jun 2016 | - | $771.03M(-395.8%) | $1.28B(-805.0%) |
| Mar 2016 | - | -$260.63M(-132.2%) | -$181.84M(-1285.3%) |
| Dec 2015 | $15.28M(-99.7%) | $808.48M(-2294.3%) | $15.34M(-98.9%) |
| Sep 2015 | - | -$36.85M(-94.7%) | $1.41B(-48.8%) |
| Jun 2015 | - | -$692.85M(+992.0%) | $2.76B(-25.5%) |
| Mar 2015 | - | -$63.45M(-102.9%) | $3.71B(-19.6%) |
| Dec 2014 | $4.59B(-39.6%) | $2.21B(+68.4%) | $4.61B(-2.9%) |
| Sep 2014 | - | $1.31B(+415.7%) | $4.75B(-17.8%) |
| Jun 2014 | - | $254.04M(-69.7%) | $5.78B(-18.0%) |
| Mar 2014 | - | $839.39M(-64.2%) | $7.05B(-7.2%) |
| Dec 2013 | $7.59B(+122.7%) | $2.34B(+0.1%) | $7.59B(+9.8%) |
| Sep 2013 | - | $2.34B(+53.6%) | $6.92B(+101.0%) |
| Jun 2013 | - | $1.52B(+10.0%) | $3.44B(-7.2%) |
| Mar 2013 | - | $1.38B(-16.8%) | $3.71B(+8.6%) |
| Dec 2012 | $3.41B(-50.2%) | $1.67B(-246.9%) | $3.41B(-12.4%) |
| Sep 2012 | - | -$1.13B(-163.4%) | $3.90B(-48.0%) |
| Jun 2012 | - | $1.79B(+63.8%) | $7.49B(+9.0%) |
| Mar 2012 | - | $1.09B(-49.2%) | $6.87B(-0.2%) |
| Dec 2011 | $6.85B | $2.15B(-12.7%) | $6.88B(+17.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | $2.46B(+110.9%) | $5.85B(+36.7%) |
| Jun 2011 | - | $1.17B(+5.9%) | $4.28B(-21.2%) |
| Mar 2011 | - | $1.10B(-1.6%) | $5.43B(-25.2%) |
| Dec 2010 | $6.96B(-16.2%) | $1.12B(+25.6%) | $7.27B(-10.8%) |
| Sep 2010 | - | $892.25M(-61.5%) | $8.14B(-19.0%) |
| Jun 2010 | - | $2.32B(-21.0%) | $10.05B(+6.3%) |
| Mar 2010 | - | $2.93B(+46.7%) | $9.45B(+9.8%) |
| Dec 2009 | $8.31B(-4.7%) | $2.00B(-28.6%) | $8.60B(+6.8%) |
| Sep 2009 | - | $2.80B(+62.7%) | $8.06B(+1.1%) |
| Jun 2009 | - | $1.72B(-17.6%) | $7.97B(-0.3%) |
| Mar 2009 | - | $2.09B(+43.5%) | $8.00B(-11.9%) |
| Dec 2008 | $8.72B(+11.8%) | $1.45B(-46.4%) | $9.08B(-0.6%) |
| Sep 2008 | - | $2.71B(+55.6%) | $9.13B(-0.8%) |
| Jun 2008 | - | $1.74B(-45.0%) | $9.21B(-0.7%) |
| Mar 2008 | - | $3.17B(+110.3%) | $9.28B(+18.5%) |
| Dec 2007 | $7.80B(+58.9%) | $1.51B(-46.0%) | $7.83B(-3.4%) |
| Sep 2007 | - | $2.79B(+54.0%) | $8.11B(+75.2%) |
| Jun 2007 | - | $1.81B(+5.3%) | $4.63B(+7.3%) |
| Mar 2007 | - | $1.72B(-3.6%) | $4.32B(-18.3%) |
| Dec 2006 | $4.91B(-42.5%) | $1.79B(-358.5%) | $5.28B(+2.4%) |
| Sep 2006 | - | -$691.40M(-146.1%) | $5.16B(-40.5%) |
| Jun 2006 | - | $1.50B(-44.3%) | $8.68B(-9.7%) |
| Mar 2006 | - | $2.69B(+61.6%) | $9.62B(+6.0%) |
| Dec 2005 | $8.53B(+24.8%) | $1.67B(-41.2%) | $9.07B(+6.7%) |
| Sep 2005 | - | $2.83B(+16.4%) | $8.50B(+4.2%) |
| Jun 2005 | - | $2.43B(+13.5%) | $8.15B(+5.7%) |
| Mar 2005 | - | $2.14B(+96.0%) | $7.71B(+6.6%) |
| Dec 2004 | $6.84B(+7.5%) | $1.09B(-56.0%) | $7.23B(-0.5%) |
| Sep 2004 | - | $2.48B(+24.8%) | $7.27B(-2.5%) |
| Jun 2004 | - | $1.99B(+19.5%) | $7.46B(+9.6%) |
| Mar 2004 | - | $1.67B(+47.2%) | $6.80B(+2.9%) |
| Dec 2003 | $6.36B(-0.6%) | $1.13B(-57.7%) | $6.61B(-0.8%) |
| Sep 2003 | - | $2.67B(+100.2%) | $6.66B(+8.8%) |
| Jun 2003 | - | $1.33B(-9.6%) | $6.13B(-9.9%) |
| Mar 2003 | - | $1.48B(+24.9%) | $6.80B(+1.7%) |
| Dec 2002 | $6.40B(+30.1%) | $1.18B(-44.6%) | $6.69B(-4.8%) |
| Sep 2002 | - | $2.13B(+6.3%) | $7.03B(+11.1%) |
| Jun 2002 | - | $2.01B(+47.2%) | $6.32B(+5.8%) |
| Mar 2002 | - | $1.36B(-10.0%) | $5.98B(+15.2%) |
| Dec 2001 | $4.92B(+11.1%) | $1.52B(+5.9%) | $5.19B(-811.6%) |
| Sep 2001 | - | $1.43B(-14.0%) | -$729.27M(-148.2%) |
| Jun 2001 | - | $1.66B(+189.7%) | $1.51B(+699.3%) |
| Mar 2001 | - | $574.60M(-113.1%) | $189.40M(-83.3%) |
| Dec 2000 | $4.43B(+17.7%) | -$4.40B(-219.7%) | $1.14B(-79.5%) |
| Sep 2000 | - | $3.68B(+979.9%) | $5.54B(+197.5%) |
| Jun 2000 | - | $340.38M(-77.6%) | $1.86B(+22.4%) |
| Mar 2000 | - | $1.52B | $1.52B |
| Dec 1999 | $3.76B(+89.4%) | - | - |
| Dec 1998 | $1.99B(-14.3%) | - | - |
| Dec 1997 | $2.32B(-0.1%) | - | - |
| Dec 1996 | $2.32B(-29.7%) | - | - |
| Dec 1995 | $3.30B(+108.7%) | - | - |
| Jun 1994 | $1.58B(+14.2%) | - | - |
| Jun 1993 | $1.39B(+51.4%) | - | - |
| Jun 1992 | $915.75M(+61.7%) | - | - |
| Jun 1991 | $566.21M | - | - |
FAQ
- What is GSK plc annual free cash flow?
- What is the all time high annual FCF for GSK plc?
- What is GSK plc annual FCF year-on-year change?
- What is GSK plc quarterly free cash flow?
- What is the all time high quarterly FCF for GSK plc?
- What is GSK plc quarterly FCF year-on-year change?
- What is GSK plc TTM free cash flow?
- What is the all time high TTM FCF for GSK plc?
- What is GSK plc TTM FCF year-on-year change?
What is GSK plc annual free cash flow?
The current annual FCF of GSK is $3.97B
What is the all time high annual FCF for GSK plc?
GSK plc all-time high annual free cash flow is $8.72B
What is GSK plc annual FCF year-on-year change?
Over the past year, GSK annual free cash flow has changed by -$1.00B (-20.18%)
What is GSK plc quarterly free cash flow?
The current quarterly FCF of GSK is $1.63B
What is the all time high quarterly FCF for GSK plc?
GSK plc all-time high quarterly free cash flow is $4.27B
What is GSK plc quarterly FCF year-on-year change?
Over the past year, GSK quarterly free cash flow has changed by +$1.08B (+194.53%)
What is GSK plc TTM free cash flow?
The current TTM FCF of GSK is $5.47B
What is the all time high TTM FCF for GSK plc?
GSK plc all-time high TTM free cash flow is $10.05B
What is GSK plc TTM FCF year-on-year change?
Over the past year, GSK TTM free cash flow has changed by -$374.98M (-6.41%)